LIBRAX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Librax, and what generic alternatives are available?
Librax is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in LIBRAX is chlordiazepoxide hydrochloride; clidinium bromide. There are nine drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the chlordiazepoxide hydrochloride; clidinium bromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Librax
A generic version of LIBRAX was approved as chlordiazepoxide hydrochloride; clidinium bromide by NUVO PHARMS INC on July 7th, 2020.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LIBRAX?
- What are the global sales for LIBRAX?
- What is Average Wholesale Price for LIBRAX?
Summary for LIBRAX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 4 |
| Patent Applications: | 4 |
| Drug Prices: | Drug price information for LIBRAX |
| What excipients (inactive ingredients) are in LIBRAX? | LIBRAX excipients list |
| DailyMed Link: | LIBRAX at DailyMed |
Pharmacology for LIBRAX
| Drug Class | Anticholinergic Benzodiazepine |
| Mechanism of Action | Cholinergic Antagonists |
| Physiological Effect | Decreased Parasympathetic Acetylcholine Activity Digestive/GI System Activity Alteration GI Motility Alteration |
US Patents and Regulatory Information for LIBRAX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch | LIBRAX | chlordiazepoxide hydrochloride; clidinium bromide | CAPSULE;ORAL | 012750-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LIBRAX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bausch | LIBRAX | chlordiazepoxide hydrochloride; clidinium bromide | CAPSULE;ORAL | 012750-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
